[Federal Register Volume 69, Number 130 (Thursday, July 8, 2004)]
[Notices]
[Page 41269]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-15462]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, National Cooperative Drug Discovery 
Groups for Tuberculosis.
    Date: August 3, 2004.
    Time: 8:30 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 6700B Rockledge Drive, 3143, Bethesda, MD 20892 
(Telephone Conference Call).
    Contact Person: Lynn Rust, PhD, Scientific Review Administrator, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892-7616, (301) 496-2550.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

     June 29, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-15462 Filed 7-7-04; 8:45 am]
BILLING CODE 4140-01-M